Skip to main content
SpringerLink
Log in

Linezolid-related haematological toxicity in a peritoneal dialysis patient: the role of therapeutic drug monitoring

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Wu VC, Wang YT, Wang CY, Tsai IJ, Wu KD, Hwang JJ et al (2006) High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease. Clin Infect Dis 42:66–72

    Article  PubMed  Google Scholar 

  2. Lin YH, Wu VC, Tsai IJ, Ho YL, Hwang JJ, Tsau YK et al (2006) High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency. Int J Antimicrob Agents 28:345–351

    Article  CAS  PubMed  Google Scholar 

  3. Matsumoto K, Takeshita A, Ikawa K, Shigemi A, Yaji K, Shimodozono Y et al (2010) Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction. Int J Antimicrob Agents 36:179–181

    Article  CAS  PubMed  Google Scholar 

  4. Hiraki Y, Tsuji Y, Misumi N, Hiraike M, Matsumoto K, Morita K et al (2013) Pharmacokinetics and elimination efficiency of linezolid during dialysis. Ren Fail 35:418–420

    Article  CAS  PubMed  Google Scholar 

  5. Cattaneo D, Orlando G, Cozzi V, Cordier L, Baldelli S, Merli S et al (2013) Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with Gram-positive infections. Int J Antimicrob Agents 41:586–589

    Article  CAS  PubMed  Google Scholar 

  6. Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A et al (2010) International Society for Peritoneal Dialysis. Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 30:393–423

    Article  PubMed  Google Scholar 

  7. Song IJ, Seo JW, Kwon YE, Kim YL, Lim TS, Kang EW et al (2014) Successful treatment of vancomycin-resistant Enterococcus peritonitis using linezolid without catheter removal in a peritoneal dialysis patient. Perit Dial Int 34:235–239

    Article  PubMed  Google Scholar 

  8. Kuter DJ, Tillotson GS (2001) Hematologic effects of antimicrobials: focus on the oxazolidinone linezolid. Pharmacotherapy 21:1010–1013

    Article  CAS  PubMed  Google Scholar 

  9. Boak LM, Rayner CR, Grayson ML, Paterson DL, Spelman D, Khumra S et al (2014) Clinical population pharmacokinetics and toxicodynamics of linezolid. Antimicrob Agents Chemother 58:2334–2343

    Article  PubMed Central  PubMed  Google Scholar 

  10. DePestel DD, Peloquin CA, Carver PL (2003) Peritoneal dialysis fluid concentrations of linezolid in the treatment of vancomycin-resistant Enterococcus faecium peritonitis. Pharmacotherapy 23:1322–1326

    Article  PubMed  Google Scholar 

  11. Di Paolo A, Malacarne P, Guidotti E, Danesi R, Del Tacca M (2010) Pharmacological issues of linezolid: an updated critical review. Clin Pharmacokinet 49:439–447

    Article  PubMed  Google Scholar 

Download references

Transparency declarations

None to declare.

Funding

This study was carried out as part of our routine work.

Conflict of interest

All the authors declare no conflict of interest.

Compliance with ethical standards

This is a retrospective observation describing a case; the patient provided written consent for the case report.

Author information

Authors and Affiliations

  1. Department of Infectious Diseases, Luigi Sacco University Hospital, Via GB Grassi 74, 20157, Milan, Italy

    Cristina Gervasoni & Roberta Terzi

  2. Unit of Clinical Pharmacology, L. Sacco University Hospital, Milan, Italy

    Dario Cattaneo

  3. Unit of Nephrology and Dialysis, L. Sacco University Hospital, Milan, Italy

    Marco Heidempergher

  4. Clinical Pharmacology Unit, CNR Institute of Neuroscience, Department of Biomedical and Clinical Sciences, L. Sacco University Hospital, Università di Milano, 20157, Milan, Italy

    Emilio Clementi

  5. Scientific Institute IRCCS E. Medea, 23842, Bosisio Parini, Italy

    Emilio Clementi

Authors
  1. Cristina Gervasoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roberta Terzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marco Heidempergher
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Emilio Clementi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dario Cattaneo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cristina Gervasoni.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gervasoni, C., Terzi, R., Heidempergher, M. et al. Linezolid-related haematological toxicity in a peritoneal dialysis patient: the role of therapeutic drug monitoring. Eur J Clin Pharmacol 71, 383–385 (2015). https://doi.org/10.1007/s00228-015-1809-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-015-1809-z

Keywords

Search

Navigation